Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current antifungal treatment of fusariosis
Abdullah M. S. Al‐Hatmi, Alexandro Bonifáz, Stéphane Ranque, et al.
International Journal of Antimicrobial Agents (2017) Vol. 51, Iss. 3, pp. 326-332
Open Access | Times Cited: 105

Showing 1-25 of 105 citing articles:

Epitypification of Fusarium oxysporum – clearing the taxonomic chaos
L. Lombard, Marcelo Sandoval‐Denis, S. C. Lamprecht, et al.
Persoonia - Molecular Phylogeny and Evolution of Fungi (2018) Vol. 43, Iss. 1, pp. 1-47
Open Access | Times Cited: 188
Human fusariosis: An emerging infection that is difficult to treat
Bruna Gerardon Batista, Magda Antunes de Chaves, Paula Reginatto, et al.
Revista da Sociedade Brasileira de Medicina Tropical (2020) Vol. 53
Open Access | Times Cited: 104
No to Neocosmospora : Phylogenomic and Practical Reasons for Continued Inclusion of the Fusarium solani Species Complex in the Genus Fusarium
Kerry O’Donnell, Abdullah M. S. Al‐Hatmi, Takayuki Aoki, et al.
mSphere (2020) Vol. 5, Iss. 5
Open Access | Times Cited: 83
Probiotics and their postbiotics for the control of opportunistic fungal pathogens: A review
S. Divyashree, B. Shruthi, P.R. Vanitha, et al.
Biotechnology Reports (2023) Vol. 38, pp. e00800-e00800
Open Access | Times Cited: 26
Outbreak of Fusarium solani Meningitis in Immunocompetent Persons Associated With Neuraxial Blockade in Durango, Mexico, 2022–2023
Gabriel García-Rodríguez, Célida Duque-Molina, Irasema Kondo-Padilla, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 2
Open Access | Times Cited: 14
Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis
Sondus Alkhazraji, Teclegiorgis Gebremariam, Abdullah Alqarihi, et al.
Antimicrobial Agents and Chemotherapy (2019) Vol. 64, Iss. 3
Open Access | Times Cited: 71
Recent Advances in the Treatment of Scedosporiosis and Fusariosis
Matthew W. McCarthy, Aspasia Katragkou, Εlias Iosifidis, et al.
Journal of Fungi (2018) Vol. 4, Iss. 2, pp. 73-73
Open Access | Times Cited: 68
Antifungal Susceptibility Testing of Fusarium: A Practical Approach
Abdullah M. S. Al‐Hatmi, Ilse Curfs-Breuker, GSybren de Hoog, et al.
Journal of Fungi (2017) Vol. 3, Iss. 2, pp. 19-19
Open Access | Times Cited: 67
Molecular Characterization and Antifungal Susceptibility of Clinical Fusarium Species From Brazil
Patricia Fernanda Herkert, Abdullah M. S. Al‐Hatmi, Gabriel Lucca de Oliveira Salvador, et al.
Frontiers in Microbiology (2019) Vol. 10
Open Access | Times Cited: 63
Consensus guidelines for the diagnosis and management of invasive fungal disease due to moulds other than Aspergillus in the haematology/oncology setting, 2021
Olivia Bupha‐Intr, Coen Butters, Gemma Reynolds, et al.
Internal Medicine Journal (2021) Vol. 51, Iss. S7, pp. 177-219
Open Access | Times Cited: 43
Multicenter Retrospective Study of Invasive Fusariosis in Intensive Care Units, France
Jordane Demonchy, Lucie Biard, Raphaël Clère-Jehl, et al.
Emerging infectious diseases (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 7
<p>Multiresistant <em>Fusarium</em> Pathogens on Plants and Humans: Solutions in (from) the Antifungal Pipeline?</p>
Abdullah M. S. Al‐Hatmi, Sybren de Hoog, Jacques F. Meis
Infection and Drug Resistance (2019) Vol. Volume 12, pp. 3727-3737
Open Access | Times Cited: 40
Isavuconazole for treatment of rare invasive fungal diseases
Oliver A. Cornely, Kathleen M. Mullane, Luis Ostrosky‐Zeichner, et al.
Mycoses (2018) Vol. 61, Iss. 8, pp. 518-533
Open Access | Times Cited: 39
Honokiol, magnolol and its monoacetyl derivative show strong anti-fungal effect on Fusarium isolates of clinical relevance
Safa Oufensou, Barbara Scherm, G Pani, et al.
PLoS ONE (2019) Vol. 14, Iss. 9, pp. e0221249-e0221249
Open Access | Times Cited: 39
Multicenter Evaluation of a PCR-Based Digital Microfluidics and Electrochemical Detection System for the Rapid Identification of 15 Fungal Pathogens Directly from Positive Blood Cultures
Sean X. Zhang, Karen C. Carroll, Shawna Lewis, et al.
Journal of Clinical Microbiology (2020) Vol. 58, Iss. 5
Open Access | Times Cited: 35
The Impact of Climate Change on Human Fungal Pathogen Distribution and Disease Incidence
Paris S. Hamm, Terry J. Torres-Cruz
Current Clinical Microbiology Reports (2024) Vol. 11, Iss. 3, pp. 140-152
Closed Access | Times Cited: 4
Diagnosis and management of invasive fungal infections due to non-Aspergillus moulds
C. Orla Morrissey
Journal of Antimicrobial Chemotherapy (2025) Vol. 80, Iss. Supplement_1, pp. i17-i39
Open Access
The Hidden Fortress: A Comprehensive Review of Fungal Biofilms with Emphasis on Cryptococcus neoformans
Hope M. Pruitt, Jinyi C. Zhu, Sean P. Riley, et al.
Journal of Fungi (2025) Vol. 11, Iss. 3, pp. 236-236
Open Access
The Dual Pathogen Fusarium: Diseases, Incidence, Azole Resistance, and Biofilms
Dongmei Li, Kincer Amburgey-Crovetti, Emilie Applebach, et al.
Journal of Fungi (2025) Vol. 11, Iss. 4, pp. 294-294
Open Access
Disseminated fusariosis successfully treated with empirical liposomal amphotericin B and voriconazole combination followed by ocular therapy in an allogenic hematopoietic stem cell transplant recipient
Yuya Kishida, Masahiro Sakaguchi, Tomoyuki Kunishige, et al.
Internal Medicine (2025)
Open Access
Non-Aspergillus Hyaline Molds: Emerging Causes of Sino-Pulmonary Fungal Infections and Other Invasive Mycoses
Samantha E. Jacobs, Nancy L. Wengenack, Thomas J. Walsh
Seminars in Respiratory and Critical Care Medicine (2020) Vol. 41, Iss. 01, pp. 115-130
Closed Access | Times Cited: 32
Potent Activities of Luliconazole, Lanoconazole, and Eight Comparators against Molecularly Characterized Fusarium Species
Mahdi Abastabar, Abdullah M. S. Al‐Hatmi, Mohammad Vafaei Moghaddam, et al.
Antimicrobial Agents and Chemotherapy (2018) Vol. 62, Iss. 5
Open Access | Times Cited: 30
Epidemiological aspects and characterization of the resistance profile of Fusarium spp. in patients with invasive fusariosis
Priscila Dallé da Rosa, Mauricio Ramírez-Castrillón, Rafael Borges, et al.
Journal of Medical Microbiology (2019) Vol. 68, Iss. 10, pp. 1489-1496
Open Access | Times Cited: 26
A review of the potential of lichen substances as antifungal agents: the effects of extracts and lichen secondary metabolites on Fusarium fungi
Łukasz Furmanek, Paweł Czarnota, M. R. D. Seaward
Archives of Microbiology (2022) Vol. 204, Iss. 8
Open Access | Times Cited: 14
Natural product‐based nanomedicine applied to fungal infection treatment: A review of the last 4 years
Gabriel Davi Marena, Matheus Aparecido dos Santos Ramos, Gabriela Corrêa Carvalho, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 7, pp. 2710-2745
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top